Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact on suicidality of the borderline personality traits impulsivity and affective instability.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2010
Same author

Migraine in affectively ill Mexican adolescents.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2010
Same author

Hypomania: a transcultural perspective.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2010
Same author

Migraine headache in affectively ill latino adults of mexican american origin is associated with bipolarity.

Primary care companion to the Journal of clinical psychiatry·2010
Same author

Irritability in depression can be a symptom of mixed depression.

Acta psychiatrica Scandinavica·2010
Same author

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

The Journal of clinical psychiatry·2009

Related Experiment Video

Updated: Jul 7, 2026

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

Defining mixed depression.

Franco Benazzi1

  • 1Hecker Psychiatry Research Center, Forli, Italy. FrancoBenazzi@FBenazzi.it

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|February 1, 2008
PubMed
Summary

Defining mixed depression by a number or score of hypomanic symptoms, rather than specific symptoms, better predicts early onset. This definition is crucial for accurate diagnosis and treatment of bipolar disorder.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • Mixed depression, characterized by a major depressive episode with co-occurring manic/hypomanic symptoms, is a growing research focus.
  • Current definitions vary, impacting diagnostic utility and treatment strategies.
  • The precise criteria for defining mixed depression remain unclear.

Purpose of the Study:

  • To evaluate which definition of mixed depression—based on specific symptoms or a symptom count/score—is more diagnostically valid.
  • To utilize early age at onset (EO) as a validator, given its association with bipolar disorder.

Main Methods:

  • Cross-sectional assessment of 336 Bipolar II Disorder (BP-II) and 224 Major Depressive Disorder (MDD) outpatients.
  • Use of the Structured Clinical Interview for DSM-IV and the Hypomania Interview Guide (HIG) to identify major depressive episodes (MDE) and hypomanic symptoms.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jul 7, 2026

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

  • Early age at onset (below 21 years) was used as the primary diagnostic validator.

    • Main Results:

    • No single hypomanic symptom independently predicted early onset.
    • A cutoff of >=3 hypomanic symptoms or a HIG score of >=8 demonstrated the best diagnostic accuracy for early onset.
    • Definitions based on symptom count/score were significantly more frequent in the early onset group and in BP-II patients compared to MDD patients.

    Conclusions:

    • Findings support the diagnostic validity of defining mixed depression by a threshold number or score of hypomanic symptoms during a depressive episode.
    • This approach aligns with previous research using bipolar family history as a validator.
    • Accurate diagnosis of mixed depression is critical for guiding treatment, particularly regarding the judicious use of antidepressants alongside mood stabilizers.